Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lodotra versus immediate-release prednisone in polymyalgia rheumatica
2011-002353-57Phase 3Terminated
- Sponsor
- Mundipharma
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisone in polymyalgia rheumatica (PMR) (2 arms), sponsored by Mundipharma. Primary endpoint: Complete responder rate at week 4. Started Oct 2012; status: terminated.
02
Drugs
prednisone
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on 2011-002353-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002353-57.